Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011;31(2):148-54.
doi: 10.3265/Nefrologia.pre2010.Nov.10724.

[New insights into the pathophysiology of oedema in nephrotic syndrome]

[Article in Spanish]
Affiliations
Free article
Review

[New insights into the pathophysiology of oedema in nephrotic syndrome]

[Article in Spanish]
H Rondon-Berrios. Nefrologia. 2011.
Free article

Abstract

Oedema is a common clinical manifestation of nephrotic syndrome. However, the pathophysiological mechanism of sodium retention in nephrotic syndrome has been intensely debated for decades. Several clinical and experimental observations argue against the classic or "underfill" hypothesis of oedema formation in nephrotic syndrome. In many patients, oedema formation in nephrotic syndrome is due to the kidney being intrinsically unable to excrete salt and is unrelated to systemic factors (i.e. hypoalbuminaemia, decreased “effective” arterial blood volume, and secondary hyperaldosteronism). The cortical collecting duct is the nephron site of sodium retention in nephrotic syndrome. Activation of the epithelial sodium channel in the cortical collecting duct is responsible for sodium retention in nephrotic syndrome. In nephrotic syndrome, a defective glomerular filtration barrier allows the passage of proteolytic enzymes or their precursors, which have the ability to activate the epithelial sodium channel, thereby causing the the subsequent sodium retention and oedema.

PubMed Disclaimer

Similar articles

Cited by

  • Fluid balance concepts in medicine: Principles and practice.
    Roumelioti ME, Glew RH, Khitan ZJ, Rondon-Berrios H, Argyropoulos CP, Malhotra D, Raj DS, Agaba EI, Rohrscheib M, Murata GH, Shapiro JI, Tzamaloukas AH. Roumelioti ME, et al. World J Nephrol. 2018 Jan 6;7(1):1-28. doi: 10.5527/wjn.v7.i1.1. World J Nephrol. 2018. PMID: 29359117 Free PMC article. Review.
  • Nutritional management of pediatric nephrotic syndrome regarding oxidative stress and antioxidant balance.
    Jechel E, Nedelcu AH, Dragan F, Lupu VV, Starcea IM, Mocanu A, Rosu ST, Streanga V, Russu R, Baciu G, Danielescu C, Salaru DL, Morariu ID, Cirstea O, Anton E, Lupu A. Jechel E, et al. Front Immunol. 2025 May 1;16:1542735. doi: 10.3389/fimmu.2025.1542735. eCollection 2025. Front Immunol. 2025. PMID: 40375997 Free PMC article. Review.
  • Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality.
    Pasini A, Aceto G, Ammenti A, Ardissino G, Azzolina V, Bettinelli A, Cama E, Cantatore S, Crisafi A, Conti G, D'Agostino M, Dozza A, Edefonti A, Fede C, Groppali E, Gualeni C, Lavacchini A, Lepore M, Maringhini S, Mariotti P, Materassi M, Mencarelli F, Messina G, Negri A, Piepoli M, Ravaglia F, Simoni A, Spagnoletta L, Montini G; NefroKid Study Group. Pasini A, et al. Pediatr Nephrol. 2015 Jan;30(1):91-101. doi: 10.1007/s00467-014-2903-7. Epub 2014 Aug 17. Pediatr Nephrol. 2015. PMID: 25127916 Free PMC article. Clinical Trial.

MeSH terms

LinkOut - more resources